Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine and ketamine for rapid sequence intubation with cisatracurium priming
IRCT20160307026950N24Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ephedrine, ketamine, cisatracurium and Normal Saline-Benha University (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Mouth opening, Jaw condition and 2 more. Started Jun 2020; status: completed.
02
Drugs
ephedrineketaminecisatracuriumNormal Saline-Benha University
Beyond the preview
Go deeper on IRCT20160307026950N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N24.